Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease
- 1 June 1987
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 59 (15) , 1319-1324
- https://doi.org/10.1016/0002-9149(87)90912-x
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Electrophysiologic evaluation of pirmenol for sustained ventricular tachycardia secondary to coronary artery diseaseThe American Journal of Cardiology, 1986
- Clinical evaluation of oral mexiletine therapy in the treatment of ventricular arrhythmiasJournal of the American College of Cardiology, 1985
- Mexiletine for control of drug-resistant ventricular tachycardia: Clinical and electrophysiologic results in 44 patientsThe American Journal of Cardiology, 1983
- Pre-column derivatization with fluorescamine and high-performance liquid chromatographic analysis of drugsJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Tocainide for refractory symptomatic ventricular arrhythmiasThe American Journal of Cardiology, 1982
- Mexiletine for refractory-ventricular arrhythmias: Results using serial electrophysiologic testingThe American Journal of Cardiology, 1981
- Tocainide for drug-resistant ventricular arrhythmias: Efficacy, side effects, and lidocaine responsiveness for predicting tocainide successAmerican Heart Journal, 1980
- Long-term tocainide therapy for ventricular arrhythmias.Circulation, 1978
- Suppression of ventricular ectopic depolarizations by tocainide.Circulation, 1977
- Lidocaine in acute myocardial infarctionAmerican Heart Journal, 1968